MGTX vs SIBN: fair value comparison
MeiraGTx Holdings plc and SI-BONE, Inc. · Updated 2026-10-19
MGTX has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. SIBN has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, SIBN currently ranks higher by quality score.
| MGTX | SIBN | |
|---|---|---|
| Verdict | No estimate yet | No estimate yet |
| Last price | $9.28 | $19.68 |
| 12-month range | $6.99–$14.97 | $11.61–$21.40 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #90 of 301 Healthcare | #89 of 301 Healthcare |
| Quality grade | C | C |
| Leverage | Moderate | Low |
| Margin trend | Contracting | Stable |
| Revenue growth | — | Strong |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Mixed | Uptrend |
| 52-week position | The lower-middle quarter | The top quarter |
Full single-stock breakdowns: MGTX fair value analysis · SIBN fair value analysis